| Original language | English |
|---|---|
| Title of host publication | Antiplatelet Therapy In Ischemic Heart Disease |
| Pages | 215-229 |
| Number of pages | 15 |
| DOIs | |
| State | Published - Feb 19 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antiplatelet agents for prevention of recurrent ischemic stroke
- Antiplatelet agents in acute ischemic stroke
- Platelet antiaggregant drugs
- Platelet antiaggregants associated with reduced risk of stroke and vascular events
- Secondary prevention with antiplatelet agents versus warfarin
- Ticlopidine Aspirin Stroke Study (TASS)
- Trifusal versus Aspirin in Cerebral Infarction Prevention (TACIP) trial
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Clinical use of Antiplatelet Agents in Cardiovascular Disease: Cerebrovascular Diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver